A single-center, single-group, observational phase 2 study evaluating HPV-16 Oncoproteins vaccine in women with HPV-16–positive, grade 3 vulvar intraepithelial neoplasia
Phase of Trial: Phase II
Latest Information Update: 22 Dec 2017
At a glance
- Drugs ISA 101 (Primary)
- Indications Vulvar intraepithelial neoplasia
- Focus Proof of concept; Therapeutic Use
- Sponsors ISA Pharmaceuticals
- 22 Dec 2017 New trial record
- 05 Nov 2009 Results published in The New England Journal of Medicine.
- 05 Nov 2009 This study was sponsored by the Dutch Cancer Society, the European Union and Pharmaceuticals, as reported in an article published at The New England Journal of Medicine.